Literature DB >> 18061151

Mitochondrial dysfunction in mouse trisomy 16 brain.

L L Bambrick1, G Fiskum.   

Abstract

Mitochondrial function in the brain of mouse trisomy 16, an animal model of Down syndrome with accelerated neuron death, was studied in isolated cortex mitochondria. Using an oxygen-sensitive Clarke electrode, a selective 16% decrease in respiration was detected with the Complex I substrates malate and glutamate but not with the Complex II substrate succinate. Western blotting revealed a 20% decrease in the 20 kDa subunit of Complex I in Ts16 brain cortex homogenates with no significant decrease in marker proteins for the other complexes of the electron transport chain. Although no differences in H(2)O(2) production or maximal calcium uptake were detected in the Ts16 mitochondria, there was an 18% decrease in pyruvate dehydrogenase levels, a change associated with oxidative stress in ischemia. These results are similar to those found in Parkinson's disease suggesting some neurodegenerative diseases may have mitochondrial pathology as a common step.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18061151     DOI: 10.1016/j.brainres.2007.10.045

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

1.  Down syndrome and dementia: a randomized, controlled trial of antioxidant supplementation.

Authors:  Ira T Lott; Eric Doran; Vinh Q Nguyen; Anne Tournay; Elizabeth Head; Daniel L Gillen
Journal:  Am J Med Genet A       Date:  2011-07-07       Impact factor: 2.802

Review 2.  Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.

Authors:  Eric D Hamlett; Heather A Boger; Aurélie Ledreux; Christy M Kelley; Elliott J Mufson; Maria F Falangola; David N Guilfoyle; Ralph A Nixon; David Patterson; Nathan Duval; Ann-Charlotte E Granholm
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

3.  Oxygen uptake kinetics during exercise in adults with Down syndrome.

Authors:  Goncalo V Mendonca; Fernando D Pereira; Bo Fernhall
Journal:  Eur J Appl Physiol       Date:  2010-06-18       Impact factor: 3.078

Review 4.  From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease.

Authors:  Kristina Leuner; Walter E Müller; Andreas S Reichert
Journal:  Mol Neurobiol       Date:  2012-07-26       Impact factor: 5.590

5.  Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia.

Authors:  Marzia Perluigi; D Allan Butterfield
Journal:  Curr Gerontol Geriatr Res       Date:  2011-11-29

6.  The use of mouse models for understanding the biology of down syndrome and aging.

Authors:  Guido N Vacano; Nathan Duval; David Patterson
Journal:  Curr Gerontol Geriatr Res       Date:  2012-02-23

7.  Validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome.

Authors:  Barbara Granese; Iris Scala; Carmen Spatuzza; Anna Valentino; Marcella Coletta; Rosa Anna Vacca; Pasquale De Luca; Generoso Andria
Journal:  BMC Med Genomics       Date:  2013-07-05       Impact factor: 3.063

Review 8.  Targeting Mitochondrial Network Architecture in Down Syndrome and Aging.

Authors:  Nunzia Mollo; Rita Cicatiello; Miriam Aurilia; Roberta Scognamiglio; Rita Genesio; Maria Charalambous; Simona Paladino; Anna Conti; Lucio Nitsch; Antonella Izzo
Journal:  Int J Mol Sci       Date:  2020-04-29       Impact factor: 5.923

9.  Knockdown of cytosolic glutaredoxin 1 leads to loss of mitochondrial membrane potential: implication in neurodegenerative diseases.

Authors:  Uzma Saeed; Lalitha Durgadoss; R Khader Valli; Dinesh C Joshi; Preeti G Joshi; Vijayalakshmi Ravindranath
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

Review 10.  Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategies.

Authors:  Giovanni Pagano; Annarita Aiello Talamanca; Giuseppe Castello; Mario D Cordero; Marco d'Ischia; Maria Nicola Gadaleta; Federico V Pallardó; Sandra Petrović; Luca Tiano; Adriana Zatterale
Journal:  Oxid Med Cell Longev       Date:  2014-05-04       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.